Evaluation of C-Met, HGF, and HER-2 Expressions in Gastric Carcinoma and Their Association With Other Clinicopathological Factors

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s107946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

HGF and C-Met in Pathogenesis of Endometrial Carcinoma

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

Expression of C-X-C Chemokine Receptor Types 1/2 in Patients With Gastric Carcinoma: Clinicopathological Correlations and Significance

Oncology Letters
Cancer ResearchOncology
2012English

Helicobacter Pylori Infection and Expressions of EGF, EGFR and C-erbB-2 Proteins in Gastric Carcinoma.

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2010English

Targeting the HGF/c-Met Axis: State of Play

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

C-Met Proto-Oncogene (MET; HGFR); Hepatocyte Growth Factor/Scatter Factor (HGF/SF)

Science-Business eXchange
2014English

Clinicopathological Significance of Claudin-4 in Gastric Carcinoma

World Journal of Surgical Oncology
SurgeryOncology
2013English

Clinicopathological Evaluation of Senile Patients With Gastric Cancer

The journal of the Japanese Practical Surgeon Society
1996English

HGF/c-Met Pathway Has a Prominent Role in Mediating Antiapoptotic Signals Through AKT in Epithelial Ovarian Carcinoma

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy